Application 212479
- Type
- NDA
- Sponsor
- THERAKIND LIMITED
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | JYLAMVO | METHOTREXATE | SOLUTION;ORAL | 2MG/ML | No | No |
| 002 | JYLAMVO | METHOTREXATE | SOLUTION;ORAL | 2MG/ML | No | No |
| 003 | JYLAMVO | METHOTREXATE | SUSPENSION;ORAL | 2MG/ML | No | No |
| 004 | JYLAMVO | METHOTREXATE | SOLUTION;ORAL | 2MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212479-001 | JYLAMVO | METHOTREXATE | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 |
| N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 |
| N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 |
| N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 |
| N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 |
| N212479-001 | 12605385 | 2035-10-25 | Drug product | 2026-05-15 | |
| N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD | 2022-11-29 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD | 2022-11-29 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD | 2022-11-29 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | 3bdfa0b2c4d7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N212479-001 | JYLAMVO | 2MG/ML | SOLUTION / ORAL | RLD, RS | 2022-11-29 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 12605385 | 2035-10-25 | Drug product | 2026-05-15 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 12605385 | 2035-10-25 | Drug product | 2026-05-15 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 12605385 | 2035-10-25 | Drug product | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 12605385 | 2035-10-25 | Drug product | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | 11771701 | 2034-10-29 | U-3700 | Drug product | 2023-10-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | 11771701 | 2034-10-29 | U-3701 | Drug product | 2023-10-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | 11771701 | 2034-10-29 | U-3702 | Drug product | 2023-10-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | 11771701 | 2034-10-29 | U-3703 | Drug product | 2023-10-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | 11771701 | 2034-10-29 | U-3704 | Drug product | 2023-10-20 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212479-001 | 11129833 | 2035-10-28 | Drug product | 2023-08-22 | 31067a03dcf5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methotrexate | METHOTREXATE | Accord Healthcare, Inc. | dd035a9f-cd40-4314-b9d8-2294b8a924e2 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | A-S Medication Solutions | 22e10810-16fb-4c84-bccf-972405b77ef8 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | AvKARE | 757d6cef-6696-7a1c-8074-01258aaa8bdd | 2026-07-23 | Boxed warning, Adverse reactions | METHOTREXATE |
| Trexall | METHOTREXATE | Teva Women's Health LLC | e942f8db-510f-44d6-acb5-b822196f5e8c | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | b6e61c50-024a-494f-b04c-100fb371a837 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 0b54b5c4-2466-4f85-b9a0-ad93ec4a06a1 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Teva Pharmaceuticals USA, Inc. | 9b34b1d8-d125-41a2-9f6f-3fab67b573bd | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Major Pharmaceuticals | 2a6afc4c-819d-4ba9-8040-4504519c116a | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Xatmep | METHOTREXATE | Azurity Pharmaceuticals, Inc. | aec9984e-34c5-481b-b6bf-9bb5caf1daf8 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Accord Healthcare Inc. | 874c7f43-a3be-4236-89cc-24c44e3c5813 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| METHOTREXATE | METHOTREXATE | Bryant Ranch Prepack | 4a04756f-e1c9-4d1e-b309-7be31c9176d6 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 4741a44f-0d0b-4380-84f6-231a8d1560fb | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | 04a95db9-a124-4b97-bd71-1c37a6b3b0c8 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Zydus Pharmaceuticals USA Inc. | 948e0bab-6524-4b87-9853-1799d4415558 | 2026-05-09 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Mylan Pharmaceuticals Inc. | 70c09984-2b36-424f-8b27-3fd0cd4e833d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Aurobindo Pharma Limited | 09931d44-a3f8-49dc-a3f2-b527ee4214bf | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | NuCare Pharmaceuticals, Inc. | 50b2cfc7-dfe4-4406-e063-6294a90a2527 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | a63364d5-4dfa-49d7-8a5e-c8959ae1d37a | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Limited | e98b2abd-8068-482e-9ce3-1ab262f0838e | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
| Methotrexate | METHOTREXATE | Golden State Medical Supply, Inc. | 6f14ced9-c16b-905a-e053-2a91aa0a031e | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | METHOTREXATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 79978 | SUPPL | 2024-10-25 |
| 79977 | SUPPL | 2024-10-25 |
| 79973 | SUPPL | 2024-10-24 |
| 79972 | SUPPL | 2024-10-24 |
| 75097 | ORIG | 2023-08-17 |
| 75096 | ORIG | 2023-08-17 |
| 75095 | ORIG | 2023-08-17 |
| 75094 | ORIG | 2023-08-17 |
| 72769 | ORIG | 2022-12-02 |
| 72768 | ORIG | 2022-12-02 |
| 72767 | ORIG | 2022-12-02 |
| 72766 | ORIG | 2022-12-02 |
| 72755 | ORIG | 2022-11-30 |
| 72754 | ORIG | 2022-11-30 |
| 72753 | ORIG | 2022-11-30 |
| 72752 | ORIG | 2022-11-30 |